Definitive Contract 75F40122C00044
Award Date
3/7/22
Potential Completion Date
3/6/27
Potential Value
$1M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
611430 - Professional and Management Development Training
PSC Category
AF11 - Education, Training, Employment, & Social Svcs R&D Svcs; Education Svcs R&D; Basic Research
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,054,685.59, was granted by the Food and Drug Administration (FDA) to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for LED training on pharmacoepidemiology, which involves the study of the use and effects of drugs in large populations. The contract does not have a set-aside designation, reflecting the University of Pennsylvania's status as a renowned private...
This federal contract award was issued by the Food and Drug Administration (FDA) to The Trustees of The University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, for a firm fixed-price delivery order. The contract, valued at $1,268.22, is to provide expertise and support for communications and an annual meeting related to the FDA's epidemiology research. The contract has no set-aside designation. The University of Pennsylvania is a prestigious private...
This is a $1,082,140.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to The Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, to conduct a randomized controlled trial re-analysis on the efficacy of chronic opioid pain treatments. The contract was awarded under Broad Agency Announcement BAA-19-00123, with a period of performance through May 1, 2025. This contract does not have a set-aside designation. The...
This is a $776,352.00 firm fixed-price definitive contract awarded by the Defense Contract Audit Agency (DCAA) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract has no set-aside designation and was awarded on September 21, 2017, with a completion date of December 20, 2020. The contract falls under the National Interest Action Code for Coronavirus COVID-19 and involves providing global perspectives on...
The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, has been awarded a definitive cost-no-fee contract valued at $4,424,934.21 by the Department of Health and Human Services Food and Drug Administration to conduct the project "Assessment of the Efficacy of Acute Pain Treatments: An RTC Re-Analysis" in Philadelphia, Pennsylvania. Under this contract, the University of Pennsylvania will analyze previously collected data...
This firm fixed-price purchase order, valued at $10,523.00, was awarded by the National Cancer Institute (NCI) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for non-federal tuition and registration fees, with a period of performance through April 11, 2025. Penn, a renowned private research university and academic medical center, has a long history of conducting cutting-edge research and providing...
This is a $10,523 firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. government, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract, which does not have a set-aside designation, is for non-federal tuition and registration fees. The University of Pennsylvania is a renowned private research university and academic medical center that provides a wide...
This is a $8,000 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for the University of Pennsylvania to provide unspecified "other functions" and was not set aside for any socioeconomic program. The University of Pennsylvania is...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to The Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, for $8,000.00. The contract is for unspecified "other functions" with a one-time charge and does not have a set-aside designation. The University of Pennsylvania is a large private research university and academic...
This is a $10,523 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to The Trustees of the University of Pennsylvania (Penn), doing business as the Clinical Practices of the University of Pennsylvania. The contract is for tuition assistance and does not have a set-aside designation. Penn is a renowned private research university and academic medical center that conducts a wide range of research and provides various services to the federal...